Ï㽶ֱ²¥

CLOSING THE ACCESS GAP

Your Zip Code Shouldn’t Influence Your Outcome

In collaboration with an impressive network of teaching hospital partners, we champion advanced care options covering our vast region.

We are steadfast in our pursuit of funding to drive research, clinical trials and community engagement efforts, ensuring that patients receive innovative treatments close to home.

Increasing Access to Specialized, Integrated Cancer Care 

Ï㽶ֱ²¥ is increasing specialized oncology care by recruiting expert faculty and providing newly FDA-approved treatments, such as immunotherapies and non-invasive surgical technologies. By integrating screening and treatment pathways with regional providers, Ï㽶ֱ²¥ can ensure timely interventions and improved patient outcomes.

These treatment pathways include connecting rural partners to cancer program hubs such as the University Medical Center’s new comprehensive academic cancer center currently under construction. Partnerships with treatment hubs will also expose trainees to rural oncology settings, expanding access to specialized care.

Current Projects

Dual-Appointed Cancer Specialist

Ï㽶ֱ²¥ is dedicated to advancing care and research in breast cancer, pediatric oncology and urology through the expertise of its faculty. Chief of the Hematology Oncology Division at Ï㽶ֱ²¥ School of Medicine, Thomas E. Hutson, D.O., Pharm.D., oversees the research, clinical and educational components of the program. Additionally, Mohamad Al-Rahawan, M.D., is a dual-appointed pediatric oncologist that has been serving the West Texas region for 10 years.

Teaching Hospital Partnership

The TLC2 Foundation, UMC Health System and Ï㽶ֱ²¥ are dedicated to constructing a new comprehensive academic cancer center in West Texas. This state-of-the-art facility will serve as a destination for cancer care, offering advanced treatment, integrative wellness programs, patient and family support and expanded opportunities for research and clinical trials.